Treatment of Severe COVID-19 Outpatients by Methylene Blue First Report

Saied Hafizi Lotfabadi, Daryoush Hamidi Alamdari and Behzad Mavaji Darban
Additional contact information
Saied Hafizi Lotfabadi: Department of Internal Medicine, Shariati Hospital, Mashhad University of Medical Sciences, Iran
Behzad Mavaji Darban: Surgical Oncology Research Center, Mashhad University of Medical Sciences, Iran

Biomedical Journal of Scientific & Technical Research, 2022, vol. 42, issue 2, 33443-33447

Abstract: There is a debate about pharmacological treatment for COVID-19. In our clinical trials...

Keywords: Immunological Disease; Nuereological Disorders; Journals on Nuero Imaging; Journals on Regenarative Diseases; Journals on Vaccination; Biomedical Open Access Journals; Biomedical Journal Impact Factor; Biomedical Journal Articles; Biomedical Journal Impact Factor; Open Access Journals on Surgery; Journals on Medical Drug and Theraputics (search for similar items in EconPapers)
Date: 2022
References: Add references at CitEc
Citations:

Downloads: (external link)
https://biomedres.us/pdfs/BJSTR.MS.ID.006723.pdf (application/pdf)
https://biomedres.us/fulltexts/BJSTR.MS.ID.006723.php (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:abf:journl:v:42:y:2022:i:2:p:33443-33447

DOI: 10.26717/BJSTR.2022.42.006723

Access Statistics for this article

Biomedical Journal of Scientific & Technical Research is currently edited by Robert Thomas

More articles in Biomedical Journal of Scientific & Technical Research from Biomedical Research Network+, LLC
Bibliographic data for series maintained by Angela Roy ().